Limit search to available items
Book Cover

Title Vitreous : in health and disease / J. Sebag, editor
Published New York : Springer, [2014]
Online access available from:
Springer eBooks    View Resource Record  


Description 1 online resource
Contents Sect. 1: Biochemistry -- I.A. Vitreous Proteins -- I.B. Hyaluronan and Other Carbohydrates in the Vitreus -- I.C. Hereditary Vitreo-Retinopathies -- I.D. Vitreous Cytokines and Regression of the Fetal Hyaloid Vasculature -- I.E. Diabetic Vitreopathy -- I.F. Vitreous Biochemistry and Artificial Vitreous -- Sect. 2: Anatomy, Development and Aging -- II. A. Development and Developmental Disorders of Vitreous -- II. B. Myopic Vitreopathy -- II. C. Vitreous Aging and Posterior Vitreous Detachment -- II. D. Hyalocytes: Essential Vitreous Cells in Vitreoretinal Health and Disease -- II. E. Vitreoretinal Interface and Inner Limiting Membrane -- II. F. To See the Invisible: The Quest of Imaging Vitreous -- Sect. 3: Pathology/Pathobiology -- III. A. Congenital Vascular Vitreoretinopathies -- III. B. Anomalous Posterior Vitreous Detachment and Vitreoschisis -- III. C. Pathology of Vitreomaculopathies -- III. D. Vitreo-Macular Adhesion/Traction and Macular Holes: Pseudo, Lamellar, and Full-Thickness -- III. E. Vitreo-Papillary Adhesion and Traction -- III. F. Vitreous in the Pathobiology of Macular Pucker -- III. G. Vitreous in Age-Related Macular Degeneration -- III. H. Peripheral Vitreo-Retinal Pathologies -- III. I. Role of Vitreous in the Pathogenesis of Retinal Detachment -- III. J. Cell Proliferation at the Vitreoretinal Interface in Proliferative Vitreoretinopathy and Related Disorders -- III. K. Vitreous in Retinovascular Diseases and Diabetic Macular Edema -- III. L. Proliferative Diabetic Vitreoretinopathy -- Sect. 4: Physiology and Pharmacotherapy -- IV. A. Vitreous Physiology -- IV. B. Oxygen in Vitreoretinal Physiology and Pathology -- IV. C. Vitreous and Iris Neovascularization -- IV. D. Physiology of Accommodation and Role of the Vitreous Body -- IV. E. Principles and Practice of Intravitreal Application of Drugs -- IV. F. Pharmacotherapy of Proliferative Vitreoretinopathy -- IV. G. Physiology of Vitreous Substitutes -- Sect. 5 pt. A: Posterior Vitreo-Retinal Surgery -- V.A.1. Age-Related Macular Degeneration Surgery -- V.A.2. Vitreomaculopathy Surgery -- V.A.3. Chromodissection in Vitreoretinal Surgery -- V.A.4. Macular Hole and Macular Pucker Surgery with Special Emphasis on Reoperations -- V.A.5. Surgery of Diabetic Vitreo-Retinopathy and Diabetic Macular Edema -- V.A.6. Vitreous Surgery of Arterial and Venous Retinovascular Diseases -- Sect. 5 pt. B: Peripheral Vitreo-Retinal Surgery -- V.B.1. The History of Vitrectomy Instrumentation: A Personal Account of a Transoceanic Australian-USA Collaboration -- V.B.2. Modern Vitrectomy Cutters: An Improved Understanding of Vitreous Cutting -- V.B.3. The Future of Vitrectomy -- V.B.4. Prophylaxis and Cure of Rhegmatogenous Retinal Detachment -- V.B.5. Management of Proliferative Vitreoretinopathy -- V.B.6. Retinectomy for Recalcitrant Retinal Detachments -- V.B.7. Pneumatic Retinopexy -- V.B.8. Vitreous Floaters and Vision: Current Concepts and Management Paradigms -- V.B.9. Rare Indications for Vitrectomy: Tumor Excision, Optic Nerve Pits, and Malignant Glaucoma -- Sect. 6: Pharmacologic Vitreolysis -- VI. A. Pharmacologic Vitreolysis -- VI. B. The History of Pharmacologic Vitreolysis -- VI. C. Pharmacologic Vitreolysis with Tissue Plasminogen Activator -- VI. D.1. Pharmacologic Vitreolysis with Plasmin: Basic Science Experiments -- VI. D.2. Pharmacologic Vitreolysis with Plasmin: Clinical Studies -- VI. E.1. Pharmacologic Vitreolysis with Ocriplasmin: Basic Science Studies -- VI. E.2. Pharmacologic Vitreolysis with Ocriplasmin: Clinical Studies -- VI. F. Hyaluronidase as a Vitreous Liquefactant -- VI. G. Pharmacologic Vitreolysis with Purified Dispase (Vitreolysin [TM]) -- VI. H. Chondroitinase as a Vitreous Interfactant: Vitreous Disinsertion in the Human -- Erratum: Vitreous Floaters and Vision: Current Concepts and Management Paradigms
Summary The vitreous body long has been the most mysterious of all ocular structures, owing perhaps to its seeming simplicity. There have been few concerted, sustained efforts to unravel the mysteries of how vitreous is composed and what role it plays in normal physiology as well as pathology. Over the years, however, many studies have produced important findings concerning vitreous biochemistry, structure, physiology, and pathobiology. Published on the 25th anniversary of Sebag's first book on Vitreous, this second installment is nearly five times longer than its predecessor, reflecting how much has been learned in the past quarter century. This well-constructed compendium not only addresses the most current scientific knowledge, but also reviews clinical perspec?tives in a manner that lends richness to the scope of the book. Written by 90 authors, this book has 56 chapters organized into 7 sections: Biochemistry; Anatomy, Development, and Aging; Pathology/Pathobiology; Physiology and Phamacotherapy; Posterior Vitreo-Retinal Surgery; Peripheral Vitreo-Retinal Surgery; and Pharmacologic Vitreolysis. With a foreword by Coleman & Lincoff and an introduction by Wallace Foulds, Sebag's latest tome on vitreous is destined to be the authoritative text for years to come
Bibliography Includes bibliographical references and index
Notes Print version record
Subject Vitreous body.
Form Electronic book
Author Sebag, J., editor
ISBN 9781493910861 (electronic bk.)
1493910868 (electronic bk.)